Stryker Corporation

New York Stock Exchange
Back to all articles
Slightly Bullish +25

JPMorgan Chase & Co. Cuts Stryker (NYSE:SYK) Price Target to $350.00

📉 JPMorgan Chase & Co. reduced its price target on Stryker from $400.00 to $350.00 while maintaining an overweight rating.

📊 The company reported Q2 EPS of $3.69, surpassing the consensus estimate of $3.49 by $0.20.

💰 Revenue for the quarter reached $6.59 billion, representing a 9.4% increase year-over-year.

📈 Stryker achieved a return on equity of 23.63% and a net margin of 14.43% during the reported period.

🎯 Management guidance for fiscal 2026 EPS is set between $14.95 and $15.10, aligning with analyst forecasts.

💵 The company paid a quarterly dividend of $0.88 per share, resulting in an annualized yield of 1.1%.

📉 Director Ronda E. Stryker sold 310,000 shares for approximately $96.8 million, reducing her ownership by 13.87%.

📉 VP Robert S. Fletcher executed a sale of 4,544 shares worth roughly $1.4 million under a Rule 10b5-1 plan.

🏦 Institutional investor Varma Mutual Pension Insurance Co increased its stake by 10.5% to own 53,610 shares.

🏦 QRG Capital Management Inc. raised its holdings by 7.4%, now owning 60,548 shares of the company.

🏦 Fulton Breakefield Broenniman LLC significantly boosted its position by 41.3% to hold 50,123 shares.

🏦 Crossmark Global Holdings Inc. grew its stake by 31.1%, acquiring an additional 6,367 shares in the quarter.

📊 The current consensus price target across analysts is $387.88 with a 'Moderate Buy' overall rating.

🏢 Institutional investors and hedge funds collectively own 77.09% of Stryker's outstanding stock.

🔬 Stryker operates globally in orthopedics, surgical equipment, neurotechnology, spine solutions, and patient-handling equipment.

Bullish Signals
  • Stryker beat earnings expectations with $3.69 EPS compared to the consensus of $3.49.
  • Revenue grew by 9.4% year-over-year to reach $6.59 billion, indicating strong top-line growth.
  • The company maintains healthy profitability metrics with a 23.63% return on equity and 14.43% net margin.
  • Fiscal 2026 guidance of $14.95-$15.10 EPS aligns closely with analyst expectations of $15.01.
  • Multiple institutional investors, including Varma Mutual Pension Insurance Co and Crossmark Global Holdings Inc., increased their stakes in the fourth quarter.
  • The company continues to pay a consistent dividend with an annualized yield of 1.1%.
Risk Factors
  • JPMorgan Chase & Co. lowered its price target from $400.00 to $350.00, signaling potential valuation concerns.
  • Director Ronda E. Stryker sold 310,000 shares worth approximately $96.8 million, representing a 13.87% reduction in her ownership.
  • VP Robert S. Fletcher sold 4,544 shares for about $1.4 million, decreasing his ownership by 30.04%.
Full Analysis
JPMorgan Chase & Co. has lowered its price target on Stryker (NYSE:SYK) from $400.00 to $350.00, maintaining an overweight rating. This adjustment comes amidst a mixed landscape of analyst opinions, with other firms like Wolfe Research setting a $375.00 objective and Citigroup lowering its target to $385.00 while keeping a buy rating. The consensus price target across the market stands at $387.88, supported by a 'Moderate Buy' consensus rating derived from one Strong Buy, seventeen Buy ratings, and five Hold ratings. Stryker recently reported strong quarterly financial results with earnings per share of $3.69, beating the consensus estimate of $3.49. Revenue reached $6.59 billion, slightly exceeding expectations at $6.58 billion, driven by a 9.4% year-over-year increase. The company demonstrated robust profitability with a return on equity of 23.63% and a net margin of 14.43%. Management has provided fiscal 2026 guidance ranging between $14.95 and $15.10 per share, which aligns closely with analyst expectations of $15.01. Institutional ownership dynamics show a divergence between insider selling and institutional buying. While Director Ronda E. Stryker and VP Robert S. Fletcher sold significant shares totaling over $98 million under pre-arranged plans, several major institutional investors increased their stakes in the fourth quarter. Notable increases include Varma Mutual Pension Insurance Co boosting its position by 10.5%, QRG Capital Management Inc. raising holdings by 7.4%, and Crossmark Global Holdings Inc. growing its stake by 31.1%.